Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO) Financial Statements


Bio-Rad Laboratories Financial Overview

Bio-Rad Laboratories's market cap is currently ―. The company's EPS TTM is $-10.367; its P/E ratio is -27.23; Bio-Rad Laboratories is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $2.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 681.18M$ 632.12M$ 681.11M$ 676.84M$ -2.07B
Gross Profit$ 366.36M$ 335.68M$ 362.48M$ 362.42M$ -2.41B
EBIT$ 440.75M$ 149.50M$ -1.49B$ 72.49M$ 1.11B
EBITDA$ 477.95M$ 149.50M$ -1.49B$ 72.49M$ 1.11B
Net Income Common Stockholders$ 349.71M$ 106.26M$ -1.16B$ 1.35B$ 833.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.61B$ 1.76B$ 1.72B$ 1.85B$ 1.79B
Total Assets$ 12.30B$ 11.12B$ 11.98B$ 13.67B$ 13.50B
Total Debt$ 1.41B$ 1.41B$ 1.38B$ 1.38B$ 1.39B
Net Debt$ -201.75M$ -353.51M$ -340.43M$ -469.74M$ -402.56M
Total Liabilities$ 3.56B$ 3.48B$ 3.53B$ 3.90B$ 3.89B
Stockholders Equity$ 8.74B$ 8.42B$ 8.45B$ 9.76B$ 9.62B
Cash Flow-
Free Cash Flow$ 38.80M$ 141.06M$ 63.47M$ 62.39M$ 227.60M
Operating Cash Flow$ 81.05M$ 185.07M$ 98.07M$ 98.12M$ 273.11M
Investing Cash Flow$ 72.20M$ -9.50M$ 27.98M$ -70.47M$ -69.31M
Financing Cash Flow$ -200.62M$ -26.60M$ -202.74M$ 4.31M$ -86.62M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

Bio-Rad Laboratories Debt to Assets

Bio-Rad Laboratories Cash Flow

Bio-Rad Laboratories Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis